Cultured human mast cells release various chemokines after stimulation with IL-33
Open Access
- 1 July 2021
- journal article
- letter
- Published by Elsevier in Allergology International
- Vol. 70 (3) , 386-388
Abstract
No abstract availableFunding Information
- National Institute of Biomedical Innovation
- National Center for Child Health and Development
This publication has 10 references indexed in Scilit:
- IL-33 induces functional CCR7 expression in human mast cellsJournal of Allergy and Clinical Immunology, 2018
- After asthma: redefining airways diseasesThe Lancet, 2018
- IL-33 fine tunes mast cell degranulation and chemokine production at the single-cell levelJournal of Allergy and Clinical Immunology, 2017
- IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized MicePLOS ONE, 2015
- A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitisJournal of Experimental Medicine, 2013
- Respiratory syncytial virus infection increases regulated on activation normal T cell expressed and secreted and monocyte chemotactic protein 1 levels in serum of patients with asthma and in human monocyte culturesAnnals of Allergy, Asthma & Immunology, 2012
- Dexamethasone and FK506 Inhibit Expression of Distinct Subsets of Chemokines in Human Mast CellsThe Journal of Immunology, 2009
- Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast CellsThe Journal of Immunology, 2007
- IL-33 can promote survival, adhesion and cytokine production in human mast cellsLaboratory Investigation, 2007
- The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway HyperresponsivenessJournal of Experimental Medicine, 1998